JP5967665B2 - Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法 - Google Patents

Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法 Download PDF

Info

Publication number
JP5967665B2
JP5967665B2 JP2013555900A JP2013555900A JP5967665B2 JP 5967665 B2 JP5967665 B2 JP 5967665B2 JP 2013555900 A JP2013555900 A JP 2013555900A JP 2013555900 A JP2013555900 A JP 2013555900A JP 5967665 B2 JP5967665 B2 JP 5967665B2
Authority
JP
Japan
Prior art keywords
milk
derived feed
range
feed
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013555900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511388A (ja
JP2014511388A5 (cg-RX-API-DMAC7.html
Inventor
ベルテルセン,ハンス
ラングボー ヴェイス,ペータ
ラングボー ヴェイス,ペータ
トルグヴァソン,チィリネ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Foods AMBA
Original Assignee
Arla Foods AMBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods AMBA filed Critical Arla Foods AMBA
Publication of JP2014511388A publication Critical patent/JP2014511388A/ja
Publication of JP2014511388A5 publication Critical patent/JP2014511388A5/ja
Application granted granted Critical
Publication of JP5967665B2 publication Critical patent/JP5967665B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
JP2013555900A 2011-03-03 2012-03-05 Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法 Active JP5967665B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161448775P 2011-03-03 2011-03-03
EP11156826 2011-03-03
US61/448,775 2011-03-03
EP11156826.7 2011-03-03
PCT/EP2012/053748 WO2012117119A1 (en) 2011-03-03 2012-03-05 Method for isolating osteopontin using feeds containing cmp or casein species

Publications (3)

Publication Number Publication Date
JP2014511388A JP2014511388A (ja) 2014-05-15
JP2014511388A5 JP2014511388A5 (cg-RX-API-DMAC7.html) 2015-02-05
JP5967665B2 true JP5967665B2 (ja) 2016-08-10

Family

ID=44202290

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013555900A Active JP5967665B2 (ja) 2011-03-03 2012-03-05 Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法
JP2013555901A Active JP6012053B2 (ja) 2011-03-03 2012-03-05 濃縮供給物を使用してオステオポンチンを単離する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013555901A Active JP6012053B2 (ja) 2011-03-03 2012-03-05 濃縮供給物を使用してオステオポンチンを単離する方法

Country Status (15)

Country Link
US (2) US9181325B2 (cg-RX-API-DMAC7.html)
EP (2) EP2681230B1 (cg-RX-API-DMAC7.html)
JP (2) JP5967665B2 (cg-RX-API-DMAC7.html)
KR (2) KR101940829B1 (cg-RX-API-DMAC7.html)
CN (3) CN103476787B (cg-RX-API-DMAC7.html)
AR (2) AR088719A1 (cg-RX-API-DMAC7.html)
AU (2) AU2012222313B2 (cg-RX-API-DMAC7.html)
BR (2) BR112013022252B1 (cg-RX-API-DMAC7.html)
CA (2) CA2828746C (cg-RX-API-DMAC7.html)
DK (2) DK2681230T3 (cg-RX-API-DMAC7.html)
EA (2) EA023615B1 (cg-RX-API-DMAC7.html)
ES (2) ES2565379T3 (cg-RX-API-DMAC7.html)
MX (2) MX2013010017A (cg-RX-API-DMAC7.html)
PL (2) PL2681230T3 (cg-RX-API-DMAC7.html)
WO (2) WO2012117119A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107257152B (zh) * 2011-04-28 2021-04-09 佐尔循环公司 用于更新数据、操作参数和/或软件的系统
JP2015516949A (ja) 2012-03-28 2015-06-18 アーラ フーズ エエムビエArla Foods amba オステオポンチンとカルシウムおよび/またはストロンチウム含有粒子とを含有するナノ粒子凝集体
MX369925B (es) * 2013-07-05 2019-11-25 Arla Foods Amba Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.
US9661868B2 (en) * 2013-07-16 2017-05-30 Mead Johnson Nutrition Company Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
KR200482960Y1 (ko) 2016-04-07 2017-03-21 오숙희 고주파 얼굴 축소 시술기
IL310614A (en) * 2016-07-06 2024-04-01 Building Block Nutritionals Llc Nutritional formula
WO2018087532A1 (en) 2016-11-08 2018-05-17 Dentherapy Ltd Compositions comprising fluoride and calcium and method for preparing them
CN111447842A (zh) * 2017-12-22 2020-07-24 雀巢产品有限公司 提取物及其用途
CN109613140B (zh) * 2019-01-07 2021-10-08 雅士利国际集团有限公司 食品中酪蛋白磷酸肽的检测方法
EP4164414A4 (en) 2020-06-15 2024-07-10 Building Block Nutritionals, LLC NUTRITIONAL FORMULA
GB202010987D0 (en) 2020-07-16 2020-09-02 Dentherapy Ltd Oral care compositions and methods
EP4326076A1 (en) * 2021-04-19 2024-02-28 Société des Produits Nestlé S.A. Use of milk protein fractions as a source of osteopontin
CN113567573B (zh) * 2021-07-09 2023-06-02 黑龙江飞鹤乳业有限公司 骨桥蛋白的分离方法和分析方法
GB202110114D0 (en) 2021-07-14 2021-08-25 Dentherapy Ltd Oral care compositions for use in treaatment
WO2024056840A1 (en) 2022-09-16 2024-03-21 Univerza V Ljubljani Isolation of osteopontin and glycomacropeptide from whey
WO2025008636A1 (en) 2023-07-06 2025-01-09 Dentherapy Ltd Oral care compositions for use in the treatment of dental health conditions
CN117837766A (zh) * 2023-12-27 2024-04-09 美维仕(北京)健康管理有限公司 营养组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU712430B2 (en) 1996-10-01 1999-11-04 Massey University Process for isolating high purity glycomacropeptide from dairy products
WO1999033415A1 (en) 1997-12-31 1999-07-08 Depuy Orthopaedics, Inc. Osteopontin-based compositions for enhancing bone repair
CN103641885A (zh) 1998-05-06 2014-03-19 基因技术股份有限公司 用离子交换层析纯化蛋白质
US7018665B2 (en) * 1999-12-08 2006-03-28 Massey University Process for separation of whey proteins using a novel anion exchanger
EP1244702B1 (en) * 2000-01-07 2006-04-26 Arla Foods amba Process for isolation of osteopontin from milk
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP

Also Published As

Publication number Publication date
EP2681231A1 (en) 2014-01-08
AU2012222313B2 (en) 2017-06-15
NZ614872A (en) 2015-07-31
EA201391204A1 (ru) 2014-02-28
CN105085649B (zh) 2019-08-16
DK2681231T3 (en) 2016-03-21
DK2681230T3 (en) 2016-03-21
MX2013010017A (es) 2014-08-01
KR20140029399A (ko) 2014-03-10
JP2014511388A (ja) 2014-05-15
JP6012053B2 (ja) 2016-10-25
CA2828669C (en) 2019-06-04
CN103492408B (zh) 2015-07-29
CA2828746C (en) 2019-05-07
AU2012222312A1 (en) 2013-09-19
AU2012222312B2 (en) 2017-06-08
JP2014508157A (ja) 2014-04-03
PL2681230T3 (pl) 2016-07-29
KR101940830B1 (ko) 2019-01-21
KR101940829B1 (ko) 2019-01-21
EA023615B1 (ru) 2016-06-30
AR088719A1 (es) 2014-07-02
CA2828746A1 (en) 2012-09-07
US9181325B2 (en) 2015-11-10
BR112013022252B1 (pt) 2020-12-22
WO2012117119A1 (en) 2012-09-07
US20140066607A1 (en) 2014-03-06
NZ614874A (en) 2015-07-31
PL2681231T3 (pl) 2016-07-29
BR112013022251A2 (pt) 2018-06-12
EP2681231B1 (en) 2015-12-16
CN103492408A (zh) 2014-01-01
CN103476787B (zh) 2016-03-09
AR085620A1 (es) 2013-10-16
CN103476787A (zh) 2013-12-25
ES2565380T3 (es) 2016-04-04
MX2013010019A (es) 2014-05-20
EP2681230A1 (en) 2014-01-08
EA023367B1 (ru) 2016-05-31
ES2565379T3 (es) 2016-04-04
BR112013022251B1 (pt) 2020-03-31
US9181316B2 (en) 2015-11-10
US20140051831A1 (en) 2014-02-20
AU2012222313A1 (en) 2013-09-19
EP2681230B1 (en) 2015-12-16
HK1217961A1 (zh) 2017-01-27
CA2828669A1 (en) 2012-09-07
KR20140029398A (ko) 2014-03-10
EA201391203A1 (ru) 2014-02-28
WO2012117120A1 (en) 2012-09-07
BR112013022252A2 (pt) 2018-06-12
CN105085649A (zh) 2015-11-25

Similar Documents

Publication Publication Date Title
JP5967665B2 (ja) Cmpまたはカゼイン種を含有する供給物を使用してオステオポンチンを単離する方法
AU2003218623B2 (en) A process of isolating lactoferrin
JPH04330100A (ja) κ−カゼイングリコマクロペプチドの製造法
NZ614872B2 (en) Method for isolating osteopontin using feeds containing cmp or casein species
HK1217961B (zh) 使用包含cmp或酪蛋白种类的给料分离骨桥蛋白的方法
NZ614874B2 (en) Method for isolating osteopontin using concentrated feeds
CN116836257A (zh) 骨桥蛋白纯化方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141211

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141211

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160215

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160607

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160629

R150 Certificate of patent or registration of utility model

Ref document number: 5967665

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250